An intriguing new study being published in next month’s issue of the journal Critical Care Medicine, and published online early by the National Institute of Health, has found that cannabinoid-based medicine administered through IV may provide a method of helping an individual resuscitate from cardiac arrest.
According to researchers, who examined rate models of cardiac arrest, “Blood temperatures decreased from 37°C to 33°C in 4 hours in animals in WIN55, 212-2 [cannabinoid receptor agonist]hypothermia group.. There was a significant improvement in myocardial function in the animals treated with WIN55, 212-2 hypothermia beginning at 1 hour after start of infusion.”
They continue; “WIN55, 212-2 hypothermia group was associated with significantly improved neurologic deficit scores and survival time when compared with placebo control group and WIN55, 212-2 with normal body temperature group.”
They conclude that; “In a rat model of cardiac arrest, better postresuscitation myocardial function, neurological deficit scores, and longer duration of survival were observed by the pharmacologically induced hypothermia with WIN55, 212-2. The improved outcomes of cardiopulmonary resuscitation following administration of WIN55, 212-2 appeared to be the results from its temperature reduction effects.”
The study, which can be found by clicking here, was conducted by researchers at the Weil Institute of Critical Care Medicine, and the Keck School of Medicine at the University of Southern California.